Original language | English |
---|---|
Pages (from-to) | S78-S79 |
Journal | European Journal of Cancer |
Volume | 174 |
DOIs | |
Publication status | Published - 1 Oct 2022 |
Preclinical activity of NVL-655 in patient-derived models of ALK cancers, including those with lorlatinib-resistant G1202R/L1196M compound mutation
T. Fujino, L. Nguyen, S. Yoda, M. Yu, H. Mizuta, L. Bigot, C. Nobre, A. Tangpeerachaikul, H. E. Pelish, L. Friboulet, J. Lee, B. Cho, A. N. Hata
Research output: Contribution to journal › Article › peer-review
1
Citation
(Scopus)